Salwa Alshehri

University of Jeddah

Papers

1

Total Citations

15

H-Index

1

About

Salwa Alshehri is a pioneering researcher at the intersection of tissue engineering, cancer biology, and bioprinting technology. Her work centers on developing advanced three-dimensional in vitro models to study hematological malignancies, particularly acute myeloid leukemia (AML). Alshehri’s most notable contribution is the fabrication of a three-dimensional bone marrow niche-like AML disease model using an automated, controlled robotic multicellular bioprinting system. This innovative approach, detailed in her highly cited 2023 paper (15 citations), recreates the complex bone marrow microenvironment to better understand drug resistance and disease relapse mechanisms—a critical step toward identifying novel therapies. By integrating robotics with tissue engineering, she has established a reproducible platform that bridges the gap between traditional 2D cultures and costly animal models. Her work has significant implications for personalized medicine, enabling more accurate testing of targeted treatments. Alshehri’s research exemplifies how biofabrication can transform preclinical oncology, offering a powerful tool to dissect the cellular and molecular interactions driving AML persistence. Her achievements mark her as a rising leader in the field of disease modeling and bioprinting.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system
15 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 20
🏛 Institutions: University of Jeddah

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago